Quadrature Capital Ltd Invests $4.05 Million in Colgate-Palmolive (NYSE:CL)

Quadrature Capital Ltd acquired a new stake in Colgate-Palmolive (NYSE:CLFree Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 50,761 shares of the company’s stock, valued at approximately $4,046,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vest Financial LLC boosted its position in shares of Colgate-Palmolive by 25.1% during the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after purchasing an additional 74,337 shares in the last quarter. Central Bank & Trust Co. boosted its position in shares of Colgate-Palmolive by 22.1% during the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after purchasing an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC boosted its position in shares of Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after purchasing an additional 910 shares in the last quarter. Sarasin & Partners LLP boosted its position in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after purchasing an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC boosted its position in shares of Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after purchasing an additional 172 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of CL stock traded down $0.09 on Friday, hitting $93.89. 2,596,198 shares of the stock traded hands, compared to its average volume of 3,510,617. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. The company has a market capitalization of $77.03 billion, a PE ratio of 29.71, a PEG ratio of 3.46 and a beta of 0.39. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $95.59. The company’s fifty day moving average is $91.12 and its 200 day moving average is $85.62.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.73 EPS. On average, equities research analysts predict that Colgate-Palmolive will post 3.53 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd were given a $0.50 dividend. The ex-dividend date was Friday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.13%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider John W. Kooyman sold 3,497 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CL has been the subject of several research reports. Morgan Stanley lifted their price target on Colgate-Palmolive from $101.00 to $103.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 28th. Citigroup lifted their price target on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, April 16th. Barclays lifted their price target on Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 30th. Stifel Nicolaus lifted their price target on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, April 29th. Finally, Argus lifted their price target on Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research note on Wednesday, May 15th. Three research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $92.94.

View Our Latest Report on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.